此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Sinew Acupuncture for Knee Osteoarthritis

2018年12月11日 更新者:The University of Hong Kong

Sinew Acupuncture for Knee Osteoarthritis (KOA): A Randomized, Sham Controlled, Patient and Assessor Blinded, Pilot Trial

The study aims to exam whether sinew acupuncture can relieve pain and symptoms of KOA and improve functional movement by Visual Analog Scale (VAS), Western Ontario and McMasters University Osteoarthritis Index (WOMAC), Timed up & Go Test (TUG) and 8-step Stair Climb Test (SCT) assessment, and Quality of life by Short Form-36 (SF-36). A randomized, sham acupuncture controlled, patient and assessor blinded, pilot study will be employed.

研究概览

详细说明

Objective:

The proposal aims to examine the efficacy and safety of sinew acupuncture for knee osteoarthritis (KOA).

Hypothesis to be tested:

Sinew acupuncture can reduce pain intensity, and improve knee function and health-related quality of life without significant side effects for KOA subjects compared to a sham acupuncture.

Design:

A randomized, subject- and assessor-blind, sham acupuncture-controlled clinical trial

Participants:

Subjects (N=86) will be randomized into sinew acupuncture or sham acupuncture group (in 1:1 ratio).

Study instrument:

Visual Analog Scale (VAS), Western Ontario and McMasters University Osteoarthritis Index (WOMAC), Timed up & Go Test (TUG), 8-step Stair Climb Test (SCT) assessment, and the Short Form-36 (SF-36).

Intervention:

Sinew acupuncture group will receive 10 sessions of needling in 4 weeks. Sham group will receive the non-invasive intervention with the same procedures. All subjects are followed up for 6 weeks.

Main outcome measures:

VAS for knee pain intensity at week 4 serves as the primary outcome. VAS at other time points, WOMAC score, TUG, SCT and SF-36 will be analyzed as the secondary outcomes.

Data analysis:

Analysis will be on the 'intention to treat' principle. T-test and mixed-effect model analysis will be used to measure primary and secondary outcomes respectively.

Expected results:

Sinew acupuncture treatment can significantly reduce knee pain intensity, and improve knee function and quality of life without obvious side effects.

研究类型

介入性

注册 (实际的)

86

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Wan Chai、香港
        • The Hong Kong Tuberculosis, Association The University of Hong Kong Clinical Centre for Teaching and Research in Chinese Medicine (Wan Chai)

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

50年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Hong Kong permanent residents aged on or above 50, both male and female;
  • meet the Clinical Classification Criteria for Osteoarthritis of the Knee by history, physical examination and radiographic findings (recommended by the American College of Rheumatology): history and physical examination: pain in the knee and one of the following (1. Over 50 years of age; 2. Less than 30 minutes of morning stiffness; 3. Crepitus on active motion and osteophytes) and radio graphical findings (Kellgren and Lawrence Grades 2-4):
  • with unilateral knee pain or bilateral knee pain;
  • in chronic stage (pain of at least 6 month's duration);
  • with rated knee pain >40 mm on a visual analog scale (VAS; 0 to 100 mm) within 7 days;
  • with X-ray or other radiographic reports are preferable (not necessary);
  • who volunteer to participate and sign the consent form;
  • able to write and read Chinese.

Exclusion Criteria:

  • Patients who are unable to walk;
  • with serious infection of knee;
  • with suspected tears of ligaments, menisci or acute inflammation of synovial capsule;
  • with trauma, ligament damage, fracture, or surgery on the knee(s) within 6 months, as the cause of pain or functional problems (history of knee replacement will be excluded);
  • with history of local tumor/malignancy at knee;
  • with physical or laboratory findings indicating infection, presence of autoimmune disease or inflammatory arthritis;
  • with knee pain caused by radiculopathy / herniation of intervertebral disc;
  • with end-stage of diseases and other suspected severe conditions such as deep vein thrombosis of the lower limb, edema related to cancer or cancer treatment, severe blood coagulation disorders, uncontrolled systemic arterial hypertension and severe diabetes;
  • with history of prolotherapy, with injections of hyaluronic acid or cortisone within 3 months;
  • received acupuncture, electro-acupuncture, Tui-na therapy, massage, physiotherapy for 8 weeks prior to the trial;
  • with more severe pain in other regions;
  • have severe mental disorders;
  • oversensitive to needles;
  • insensitive to pain due to advanced diabetes, neuropathy or using strong painkillers;
  • fail to be complaint with the treatment protocol.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:双倍的

武器和干预

参与者组/臂
干预/治疗
实验性的:Sinew acupuncture
Subject in the arm will receive real acupuncture intervention.
Sinew acupuncture: subject will sit on chair with knee joint flexion with a most comfortable angle nearest to 90 degrees. Acupoints (1-2cm away from the point of tenderness or pain) near the knee will be punctured through the skin by using sterile needles of size 0.30mm × 40mm at the angle of 0-10 degrees pointing along the pain direction and meridian sinew. Immediately, needles will be retreated back just under the skin and inserted 10mm-20mm forward smoothly with minimal pain sensation. Walking and stepping will be advised and governed during acupuncture. The acupoint will be covered with non-allergic bandages to ensure sufficient blinding to the subject. The treatment will last 20 minutes for each session.
假比较器:Sham acupuncture
Subject in the arm will receive sham acupuncture intervention.
Sham acupuncture: subject will receive the same procedures as the sinew acupuncture without penetrating the skin. The needle will be used to puncture on the acupoint slightly without passing through the skin. The acupoint will be covered with non-allergic bandages to ensure sufficient blinding to the subject.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Pain intensity measured by VAS
大体时间:Week 4
Pain intensity will be measured by VAS
Week 4

次要结果测量

结果测量
措施说明
大体时间
WOMAC
大体时间:Weeks 0, 1, 2, 3, 4, 6 and 10
Western Ontario and McMasters University Osteoarthritis Index
Weeks 0, 1, 2, 3, 4, 6 and 10
TUG
大体时间:Weeks 0, 2, 4, 6 and 10
Timed up and go test
Weeks 0, 2, 4, 6 and 10
8-step SCT
大体时间:Weeks 0, 2, 4, 6 and 10
Stair Climb Test
Weeks 0, 2, 4, 6 and 10
Quality of life measured by SF-36
大体时间:Weeks 0, 4, and 10
Short Form-36
Weeks 0, 4, and 10

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Kwok Yin Au, PhD、The Hong Kong Tuberculosis Association Chinese Medicine Clinic cum Training Centre of the University of Hong Kong

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年6月1日

初级完成 (实际的)

2018年9月30日

研究完成 (实际的)

2018年9月30日

研究注册日期

首次提交

2017年3月28日

首先提交符合 QC 标准的

2017年3月31日

首次发布 (实际的)

2017年4月4日

研究记录更新

最后更新发布 (实际的)

2018年12月13日

上次提交的符合 QC 标准的更新

2018年12月11日

最后验证

2018年12月1日

更多信息

与本研究相关的术语

其他研究编号

  • UHongKong-UW16-2007

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

未定

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

膝骨性关节炎的临床试验

3
订阅